CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at help@airdberlis.com.

Back to all publications
Jul 17, 2020

The Canadian Intellectual Property Office’s COVID-19 Response

By Erica L. Lowthers, PhD

Like many other jurisdictions, the Canadian Intellectual Property Office (CIPO) has implemented extensions of time for certain deadlines relating to patents, industrial designs and trademarks due to COVID-19. These extensions have been ongoing since March 16, 2020, and are currently set to end on August 28, 2020, meaning that certain due dates falling between March 16 and August 28, inclusive, are automatically extended to August 31. The CIPO website details how CIPO operations are being modified in view of COVID-19.

Despite these extensions being available, we recommend that all original due dates be met if possible. The extensions do not apply to all due dates and, in some cases, extensions are only available up to certain maximum time periods. Please reach out to one of our professionals if you need to discuss a particular matter.

CIPO remains open for business, but has warned of significant delays in their services while most of their staff is working remotely.

In order to encourage innovation surrounding COVID-19 inventions, CIPO has launched a pilot program for free accelerated examination of Canadian patent applications that pertain to supporting the health-related response to COVID-19. This program is limited to 50 applications for the time being and is targeted to Applicants that qualify as a small entity (a business employing 50 or fewer employees or a university) and in which the claimed invention is currently or has been subject to a Health Canada approval process.

The professionals of Aird & McBurney can help you navigate patent, industrial design and trademark applications. Details are available on our Intellectual Property webpage.

Related Publications

Publications Article
Bought an NBA Top Shot NFT? What Did You Actually Buy? By Jasraj Shergill Jul 29, 2021 2021 has seen NFTs, or “Non-Fungible Tokens,” become the centre of attention in the worlds of spo... 2021 has seen NFTs, or “Non-Fungible Tokens,” become the centre of attention in the worlds of sport, investing and blockchain. A catalyst for this rise in popularity is NBA Top Shot, a new form of licensed digital collectibles from the NBA. More than $230 million was spent on Top Shot NFTs during...
Publications Article
Department of Finance Clarifies Legislative Intent for Amendments to Taxation of Intergenerational Transfers of Businesses By Edward Miller and Robert Santia Jul 23, 2021 On July 19, 2021, the Department of Finance released a statement acknowledging that the amendment... On July 19, 2021, the Department of Finance released a statement acknowledging that the amendments contained in Bill C-208 form part of the Income Tax Act (Canada) and are now law. The July 19 Announcement replaces the June 30 news rel...
Publications Article
Bill C-208: Tax Implications for Family Businesses By Edward Miller and Robert Santia Jul 08, 2021 On June 29, 2021, Bill C-208 received royal assent. Bill C-208 contains amendments to the Income ... On June 29, 2021, Bill C-208 received royal assent. Bill C-208 contains amendments to the Income Tax Act (Canada) (the “ITA”) that impact the tax consequences of certain intergenerational transfers by providing exceptions that will allow for the extraction of corporate surplus.